MedPath

FITA pilot study evaluating the feasibility and effects of early administration of Fibrinogen concentrate In adults with Traumatic haemorrhage

Conditions
Bleeding
Traumatic haemorrhage
Blood - Clotting disorders
Injuries and Accidents - Other injuries and accidents
Registration Number
ACTRN12615001293550
Lead Sponsor
Investigator Initiated- Monash University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

1.The participant is judged to be an adult (aged 18 years or over) and is affected by traumatic injury
2.The participant is deemed by the attending clinician to have on-going active haemorrhage with shock
AND REQUIRES:
3.activation of the local massive transfusion protocol (MTP) for management of severe blood loss and/or transfusion of emergency (Group O) red cells

Exclusion Criteria

1.The participant has been transferred from another hospital
2.The trauma team leader deems the patient inappropriate for the trial i.e. injuries deemed to be incompatible with life
3.More than 3 hours have elapsed from the time of injury
4.The participant is pregnant
5.Severe isolated traumatic brain injury (TBI) or unsalvageable head injury
6.Known objection to the administration of human blood products
7.Participation in a competing study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath